![]() Repligen Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems. | ![]() Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. | ![]() Noven Pharmaceuticals Noven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products. | |
Founding Date | Founding Date 1981 | Founding Date 2010 | Founding Date 1987 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Waltham, US HQ Shanghai, CN Jüri, EE Castanet Tolosan, FR Ravensburg, DE Bengaluru, IN Waterford, IE see more | Locations Jersey City, US HQ Miami, US | |
Employees | Employees 1,78312% decrease | Employees 1,8401% increase | Employees 9401% increase |
Valuation ($) | Valuation ($) 7.7 b | Valuation ($) 11.1 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $634.4m (FY, 2024) | Revenue (est.) kr26b (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $359.8m (FY, 2024) | Cost of goods kr5.8b (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit $274.6m (FY, 2024) | Gross profit kr20.3b (FY, 2024) | Gross profit N/A |
Net income | Net income ($25.5m) (FY, 2024) | Net income kr3.9b (FY, 2024) | Net income N/A |
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
View companyNoven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products.
View company